|Prevalence of Hypertension in China: A Cross-Sectional Study|
|Gao, Yun1; Chen, Gang2; Tian, Haoming1; Lin, Lixiang2; Lu, Juming3; Weng, Jianping4; Jia, Weiping5; Ji, Linong6; Xiao, Jianzhong7; Zhou, Zhiguang8; Ran, Xingwu1; Ren, Yan1; Chen, Tao1; Yang, Wenying7; China Natl Diabet Metab Disorders1|
|WOS标题词||Science & Technology|
|研究领域[WOS]||Science & Technology - Other Topics|
|关键词[WOS]||GLUCOSE-TOLERANCE ; OBESITY ; NUTRITION ; AWARENESS ; PREVENTION ; OVERWEIGHT ; HEALTH ; TRENDS ; WOMEN ; MEN|
Aims: The present study aimed to assess the prevalence of hypertension among Chinese adults.
Methods: Data were obtained from sphygmomanometer measurements and a questionnaire administered to 46239 Chinese adults >= 20 years of age who participated in the 2007-2008 China National Diabetes and Metabolic Disorders Study. Hypertension was defined as blood pressure >= 140/90 mm Hg or use of antihypertensive medication.
Results: A total of 26.6% of Chinese adults had hypertension, and a significantly greater number of men were hypertensive than women (29.2% vs 24.1%, p<0.001). The age-specific prevalence of hypertension was 13.0%, 36.7%, and 56.5% among persons aged 20 to 44 years (young people), 45 to 64 years (middle-aged people), and >= 65 years (elderly people), respectively. In economically developed regions, the prevalence of hypertension was significantly higher among rural residents than among urban residents (31.3% vs 29.2%, p = 0.001). Among women or individuals who lived in the northern region, the disparity in the prevalence of hypertension between urban and rural areas disappeared (women: 24.0% vs. 24.0%, p = 0.942; northern region: 31.6% vs. 31.2%, p = 0.505). Among hypertensive patients, 45.0% were aware of their condition, 36.2% were treated, and 11.1% were adequately controlled.
Conclusions: The prevalence of hypertension in China is increasing. The trend of an increase in prevalence is striking in young people and rural populations. Hypertension awareness, treatment, and control are poor. Public health efforts for further improving awareness and enhancing effective control are urgently needed in China, especially in emerging populations.
|资助机构||Chinese Medical Association Foundation ; Chinese Diabetes Society|
|作者单位||1.Fujian Prov Hosp, Dept Endocrinol, Fuzhou, Peoples R China|
2.Sichuan Univ, Dept Endocrinol, West China Hosp, Chengdu 610064, Peoples R China
3.Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing, Peoples R China
4.Sun Yat Sen Univ, Hosp 3, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China
5.Shanghai Jiao Tong Univ, Dept Endocrinol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China
6.Peking Univ, Peoples Hosp, Dept Endocrinol, Beijing 100871, Peoples R China
7.China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China
8.Xiangya Second Hosp, Dept Endocrinol, Changsha, Hunan, Peoples R China
|Gao, Yun,Chen, Gang,Tian, Haoming,et al. Prevalence of Hypertension in China: A Cross-Sectional Study[J]. PLOS ONE,2013,8(6).|
|APA||Gao, Yun.,Chen, Gang.,Tian, Haoming.,Lin, Lixiang.,Lu, Juming.,...&China Natl Diabet Metab Disorders.(2013).Prevalence of Hypertension in China: A Cross-Sectional Study.PLOS ONE,8(6).|
|MLA||Gao, Yun,et al."Prevalence of Hypertension in China: A Cross-Sectional Study".PLOS ONE 8.6(2013).|